Observed and predicted growth responses in prepubertal children with growth disorders: guidance of growth hormone treatment by empirical variables
- PMID: 20097713
- DOI: 10.1210/jc.2009-1471
Observed and predicted growth responses in prepubertal children with growth disorders: guidance of growth hormone treatment by empirical variables
Abstract
Context: Information about the expected growth response of children to GH therapy is currently inadequate.
Objectives: The aim of the study was to compare observed and expected growth in response to GH in prepubertal children and to propose how these parameters can be used to optimize GH therapy. Indices considered were observed growth, observed growth relative to reference data [height sd score (Ht SDS), change in (Delta) Ht SDS, height velocity (HV)], and observed growth relative to growth predicted from prediction models [Studentized residual (SR)]. Design/Setting/Patients/Intervention: Growth data from KIGS-Pfizer International Growth Database-on prepubertal children aged 1-13 yr with severe GH deficiency (GHD; maxGH <5 microg/liter; n = 2129), with less-severe GHD (maxGH of 5-10 microg/liter; n = 3075), and with Turner syndrome (n = 2350), and short children born small for gestational age (n = 993) were analyzed before and during 2 yr of GH treatment.
Main outcome measure: For each patient group, growth responses during the first 2 yr of GH treatment were established. The relationships of HV and DeltaHt SDS with SR were determined.
Results: Reference data were generated for assessing adequate individual responses. Responses to GH in terms of HV and DeltaHt SDS were greatest in children with severe GHD. HV and DeltaHt SDS were highly correlated with SR during only the first year of GH treatment (R approximately 0.7; P < 0.001).
Conclusions: Decisions on GH therapy regimens should be made using both traditional (HV or DeltaHt SDS) and prediction model-derived (SR) indices of growth response.
Similar articles
-
Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).Horm Res. 2005;63(1):40-7. doi: 10.1159/000082872. Epub 2004 Dec 22. Horm Res. 2005. PMID: 15627781
-
Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.J Clin Endocrinol Metab. 2005 Apr;90(4):1966-71. doi: 10.1210/jc.2004-1051. Epub 2005 Jan 5. J Clin Endocrinol Metab. 2005. PMID: 15634724
-
Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study.J Clin Endocrinol Metab. 1999 Apr;84(4):1174-83. doi: 10.1210/jcem.84.4.5634. J Clin Endocrinol Metab. 1999. PMID: 10199749
-
Observed and predicted total pubertal growth during treatment with growth hormone in adolescents with idiopathic growth hormone deficiency, Turner syndrome, short stature, born small for gestational age and idiopathic short stature: KIGS analysis and review.Horm Res Paediatr. 2011;75(6):423-32. doi: 10.1159/000324117. Epub 2011 Feb 25. Horm Res Paediatr. 2011. PMID: 21358173 Review.
-
Individualised growth response optimisation (iGRO) tool: an accessible and easy-to-use growth prediction system to enable treatment optimisation for children treated with growth hormone.J Pediatr Endocrinol Metab. 2017 Oct 26;30(10):1019-1026. doi: 10.1515/jpem-2017-0120. J Pediatr Endocrinol Metab. 2017. PMID: 28902629 Review.
Cited by
-
A pharmacogenomic approach to the treatment of children with GH deficiency or Turner syndrome.Eur J Endocrinol. 2013 Jul 29;169(3):277-89. doi: 10.1530/EJE-13-0069. Print 2013 Sep. Eur J Endocrinol. 2013. PMID: 23761422 Free PMC article. Clinical Trial.
-
Criteria for First-Year Growth Response to Growth Hormone Treatment in Prepubertal Children With Growth Hormone Deficiency: Do They Predict Poor Adult Height Outcome?Front Endocrinol (Lausanne). 2019 Nov 26;10:792. doi: 10.3389/fendo.2019.00792. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31849835 Free PMC article.
-
Short and Long-Term Effects of Growth Hormone in Children and Adolescents With GH Deficiency.Front Endocrinol (Lausanne). 2021 Sep 1;12:720419. doi: 10.3389/fendo.2021.720419. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34539573 Free PMC article. Review.
-
Predicting response to growth hormone treatment.Indian J Pediatr. 2012 Feb;79(2):229-37. doi: 10.1007/s12098-011-0611-x. Epub 2011 Nov 22. Indian J Pediatr. 2012. PMID: 22105236
-
A novel approach to the analysis of human growth.Theor Biol Med Model. 2012 May 17;9:17. doi: 10.1186/1742-4682-9-17. Theor Biol Med Model. 2012. PMID: 22594680 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials